


GHK-Cu 60mg Copper Peptide
GHK-Cu (Copper Tripeptide-1) is a naturally occurring copper-binding peptide that has been researched for its involvement in tissue remodeling, extracellular-matrix activity, wound-healing pathways and skin biology. Most of the human evidence relates to topical...
GHK-Cu (Copper Tripeptide-1) is a naturally occurring copper-binding peptide that has been researched for its involvement in tissue remodeling, extracellular-matrix activity, wound-healing pathways and skin biology. Most of the human evidence relates to topical formulations, while injectable GHK-Cu remains poorly studied in humans.
Research areas include: collagen and extracellular-matrix research, skin regeneration, wound-healing pathways, cellular signalling, inflammation-related pathways and tissue remodeling. However, the evidence for injectable GHK-Cu is very limited, with no established human clinical safety or efficacy profile for systemic injection.
Important: GHK-Cu is an investigational compound, and the 60mg self-mix vial shown here is not an approved pharmaceutical formulation. Injectable GHK-Cu has also raised regulatory safety concerns relating to impurities and potential immune reactions. This product is provided for research purposes only and is not intended to diagnose, treat, cure or prevent any disease or medical condition.
| Form | Lyophilised powder |
| Purity (HPLC) | 99%+ |
| Appearance | White lyophilised solid |
| Solubility | Bacteriostatic / sterile water |
| Storage | Lyophilised at -20°C, reconstituted at 2 to 8°C |
The Certificate of Analysis for lot GX-2026 confirms an HPLC purity of 99%+ and identity confirmed by mass spectrometry.
View in COA libraryThe Safety Data Sheet describes handling, storage and disposal information for this research compound. Always follow standard laboratory safety practice.
View in SDS libraryMore like this


Tesamorelin 30mg Growth Hormone-Releasing Factor Analog

Tirzepatide 30mg GIP/GLP-1 Receptor Agonist

Semaglutide 7mg GLP-1 Receptor Agonist
Join the research list.
New compounds, batch releases and COA drops, sent before they hit the catalogue.